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Introduction
Cell motility plays a central role in various biological processes, 
including embryogenesis, immune surveillance, and wound 
healing, with spatiotemporal regulation of such motility being 
essential for homeostasis in multicellular organisms (Lauffen-
burger and Horwitz, 1996). Cell motility is induced by multiple 
extracellular cues, including gradients of chemokines, growth 
factors, and extracellular matrix components. These molecules 
engage cell surface receptors and thereby initiate a cascade of 
events such as activation of the phosphatidylinositol 3-kinase 
(PI3K) and extracellular signal–regulated kinase (ERK) signal-
ing pathways that function downstream of the small GTP-bind-
ing protein Ras (Guo and Giancotti, 2004). Activated PI3K 
catalyzes the production of phosphatidylinositol 3,4,5-trisphos-
phate (PI(3,4,5)P3), which triggers the formation of lamelli-
podia at the leading edge of a migrating cell via activation of 
the small GTPase Rac1 and the protein kinase Akt and thereby 
promotes cell motility (Raftopoulou and Hall, 2004; Vanhaese-
broeck et al., 2012; Xue and Hemmings, 2013). Activated 
ERK also modulates cell motility through direct phosphoryla-
tion of several molecules, including myosin light chain kinase 
(Klemke et al., 1997), cortactin (Martinez-Quiles et al., 2004), 
WAVE2 (Danson et al., 2007; Nakanishi et al., 2007; Mendoza 
et al., 2011), and FAK (Hunger-Glaser et al., 2003). We recently 
showed that the Src homology 3 (SH3) domain–containing pro-
tein SH3P2 is a negative regulator of cell motility whose func-
tion is abrogated by p90 ribosomal S6 kinase (RSK)–mediated 
phosphorylation at Ser202 downstream of ERK (Tanimura et al., 
2011). However, the mechanism by which SH3P2 regulates cell 
motility has remained elusive.
Myosin 1E (Myo1E) is an actin-dependent molecular 
motor that is widely expressed in vertebrate tissues (McCon-
nell and Tyska, 2010). Myo1E is a class 1 myosin, a defining 
feature of which is the ability to interact with both cell mem-
branes and actin filaments via a C-terminal tail homology 1 
(TH1) domain and an N-terminal motor domain, respectively. 
This spatial segregation of membrane and actin-binding sites 
suggests that class 1 myosins have the potential to serve as diva-
lent cross-linking proteins that physically connect and generate 
force between actin filaments and membranes and thereby to 
regulate plasma membrane tension. Whereas most class 1 myo-
sins are “short tailed” in that they possess only the TH1 domain 
in the tail region, Myo1E also contains a proline-rich membrane 
binding (TH2) domain and a protein–protein interaction (SH3) 
domain and is therefore classified as “long tailed.” Myo1E has 
been proposed to function in a manner dependent on interac-
tions mediated by its SH3 domain as a transporter or recruiter 
of effector proteins involved in myosin-based as well as actin 
nucleation–based force generation at the plasma membrane. It 
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thus contributes to the accumulation of effector molecules such 
as dynamin, synaptojanin-1, and the N-WASP–WIP complex 
at the membrane–cytoskeleton interface to support endocy-
tosis as well as cell motility (Krendel et al., 2007; Cheng et 
al., 2012). However, the molecular mechanisms by which the 
function of Myo1E, and in particular its intracellular local-
ization, are regulated have remained unknown. We have now 
identified Myo1E as a binding partner of SH3P2. We found that 
RSK-mediated phosphorylation of SH3P2 induces the dissocia-
tion of Myo1E from SH3P2 in the cytosol, which results in the 
localization of Myo1E to the tips of lamellipodia and thereby 
promotes cell motility.
Results
Identification of Myo1E as a binding 
partner of SH3P2
To identify proteins that interact with SH3P2, we performed a 
pull-down assay with MKN1 cell lysates and a GST-SH3P2 fu-
sion protein as the bait. An ∼120-kD protein was found to bind 
specifically to SH3P2 (Fig.  1  A) and was identified by mass 
spectrometry (MS) as Myo1E. Specific interaction between 
endogenous SH3P2 and Myo1E was confirmed by recipro-
cal coimmunoprecipitation assays (Fig.  1  B). The pull-down 
assay also revealed the binding of ∼66- and ∼68-kD proteins 
to SH3P2, and these two proteins were identified by MS as 
hnRNP-K and Sam68, respectively. However, given that coim-
munoprecipitation assays did not detect a specific interaction 
between endogenous SH3P2 and either of these two RNA-bind-
ing proteins (Fig. 1 B), we did not analyze them further.
SH3P2 interacts with Myo1E via 
its N-terminal proline-rich region and 
C-terminal acidic amino acid cluster
SH3P2 consists of an N-terminal proline-rich (PR) region, an 
SH3 domain, three ankyrin (ANK) repeats, and a C-terminal 
(C) region (Fig.  2 A). To determine the region of SH3P2 re-
sponsible for interaction with Myo1E, we first performed pull-
down assays with MKN1 cell lysates and GST-fused SH3P2 
deletion mutants as baits. We found that SH3P2(ΔPR) and 
SH3P2(ΔPR/SH3) as well as SH3P2(ΔC) interacted with en-
dogenous Myo1E, albeit to a slightly or substantially reduced 
extent compared with wild-type SH3P2, respectively, whereas 
neither SH3P2(ΔPR/C) nor SH3P2(ΔPR/ANK/C) showed such 
an interaction (Fig. 2 A). Coimmunoprecipitation analysis with 
lysates of MKN1 cells expressing EGFP-tagged SH3P2 dele-
tion mutants showed that deletion of the PR/SH3 or C regions 
attenuated the interaction of SH3P2 with Myo1E slightly or 
substantially, respectively, and that deletion of both PR and C 
regions abolished the interaction (Fig. 2 B).
The SH3P2 proteins of various mammalian species con-
tain a conserved acidic amino acid cluster at the C terminus 
(Fig. S1 A), whose potential role in the interaction with Myo1E 
we next examined. Coimmunoprecipitation analysis with ly-
sates of MKN1 cells expressing EGFP-tagged SH3P2(ΔC2), 
SH3P2(ΔC1), or SH3P2(ΔC) revealed that the extent of in-
teraction of these mutants with endogenous Myo1E decreased 
as the number of deleted acidic amino acid residues increased 
(Fig.  2  B). Furthermore, replacement of two (C2A mutant: 
Asp209/Asp210) or six (C6A mutant: Glu205/Asp206/Asp209/Asp210/
Glu211/Asp212) acidic amino acid residues of SH3P2 with ala-
nine reduced the extent of association with Myo1E slightly or 
markedly, respectively (Fig. 2 B). Together, these results sug-
gested that both the PR region and the C-terminal acidic amino 
acid cluster, but not the SH3 domain or ANK repeats, of SH3P2 
are required for efficient interaction with Myo1E.
Myo1E interacts with SH3P2 via its 
SH3 domain and the C-terminal positively 
charged region of its TH2 domain
Myo1E comprises an actin-activated motor head domain, a 
light-chain binding neck (IQ) domain, as well as TH1, TH2, 
and SH3 domains (Fig. 3 A). To determine the region of Myo1E 
responsible for interaction with SH3P2, we first examined the 
potential interaction between the SH3 domain of Myo1E and 
the PR region of SH3P2, given that SH3 domains recognize PR 
sequences within specific peptide sequence contexts (Ren et al., 
1993; Feng et al., 1994). A pull-down assay with the GST-fused 
SH3 domain of Myo1E as bait showed that Myo1E(SH3) bound 
to recombinant SH3P2, but not to SH3P2(ΔPR) (Fig. 3 A), sug-
gesting that the SH3 domain of Myo1E indeed contributes to 
the interaction with SH3P2 by binding to its PR region.
Coimmunoprecipitation analysis with lysates of MKN1 
cells expressing EGFP-tagged Myo1E deletion mutants revealed 
that although deletion of the SH3 domain alone did not substan-
tially affect the binding of Myo1E to endogenous SH3P2, deletion 
of TH1–TH2-SH3 or TH2-SH3 domains abolished such binding 
(Fig. 3 B), suggesting the presence of another binding site (or 
sites) within the TH2 domain. Seven basic amino acids are clus-
tered in the C-terminal region of the TH2 domain, which is con-
served among mammalian Myo1E proteins (Fig. S1 B). We next 
Figure 1. SH3P2 specifically interacts with Myo1E. (A) Glutathione- 
Sepharose beads coupled with GST or GST-SH3P2 were incubated with 
MKN1 cell lysates (+) or with the lysis buffer alone (−), after which bead-
bound proteins were subjected to SDS-PAGE followed by staining with 
Coomassie brilliant blue (CBB). Bands corresponding to proteins of ∼120, 
∼68, and ∼66 kD (arrows) pulled down by GST-SH3P2 were identified 
by MS analysis as Myo1E, Sam68, and hnRNP-K, respectively. (B) MKN1 
cell lysates were subjected to immunoprecipitation (IP) with antibodies to 
SH3P2 or to Myo1E (or with control IgG), and the resulting precipitates as 
well as the whole-cell lysates (10% of the input for immunoprecipitation) 
were subjected to immunoblot analysis (IB) with antibodies to the indicated 
proteins. All data are representative of at least three separate experiments.
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focused on the potential role of these basic amino acid residues in 
the interaction of Myo1E with SH3P2. Coimmunoprecipitation 
analysis with lysates of MKN1 cells expressing EGFP-tagged 
Myo1E mutants revealed that deletion of sequences containing 
all seven (ΔTH2-b2/SH3 mutant: Arg1029/Arg1030/Arg1035/Arg1042/
Lys1044/Lys1048/Lys1050) or the final four (ΔTH2-b1/SH3 mutant: 
Arg1042/Lys1044/Lys1048/Lys1050) of these basic amino acid resi-
dues abrogated the interaction of Myo1E(ΔSH3) with SH3P2 
(Fig. 3 B). Furthermore, replacement of Lys1048 and Lys1050 with 
alanine (2AΔSH3 mutant) reduced the extent of the interaction 
between Myo1E(ΔSH3) and SH3P2 (Fig. 3 B). These results 
suggested that the positively charged region located at the C 
terminus of the TH2 domain also contributes to the interaction 
of Myo1E with SH3P2, most likely through binding to the acidic 
amino acid cluster of the latter protein.
To confirm the presence of these two binding inter-
faces for the interaction between SH3P2 and Myo1E, we per-
formed pull-down assays with MKN1 cell lysates expressing 
EGFP-tagged Myo1E deletion mutants and with GST-fused 
SH3P2 deletion mutants as baits. As expected, SH3P2 bound 
to Myo1E and to Myo1E(ΔSH3), but not to Myo1E(ΔTH2-b2/
SH3). SH3P2(ΔPR), which possesses the C-terminal acidic 
amino acid cluster, bound to Myo1E and to Myo1E(ΔSH3), but 
not to Myo1E(ΔTH2-b2/SH3). SH3P2(ΔC), which possesses 
the PR region, bound to Myo1E, but not to Myo1E(ΔSH3) 
or Myo1E(ΔTH2-b2/SH3). Finally, SH3P2(ΔPR/C) failed to 
bind to Myo1E, Myo1E(ΔSH3), or Myo1E(ΔTH2-b2/SH3) 
(Fig. 3 C and Fig. S2).
RSK-mediated phosphorylation of SH3P2 
at Ser202 induces dissociation of Myo1E
We previously showed that RSK1, acting downstream of the 
ERK pathway, phosphorylates SH3P2 at Ser202 and thereby in-
hibits its ability to suppress cell motility (Tanimura et al., 2011). 
Figure 2. SH3P2 interacts with Myo1E via its N-terminal 
proline-rich region and C-terminal acidic amino acid cluster. 
(A) Glutathione-Sepharose beads coupled with GST or GST-
tagged wild-type or indicated mutant forms of human SH3P2 
were incubated with MKN1 cell lysates, after which bead-
bound proteins as well as the whole-cell lysates (10% of the 
input for the pull-down assays) were subjected to SDS-PAGE 
followed by staining with Coomassie brilliant blue (CBB) or 
immunoblot analysis (IB) with antibodies to Myo1E. Arrow-
heads indicate the Myo1E band. (B) MKN1 cells were trans-
fected for 24 h with vectors encoding EGFP-tagged wild-type 
or mutant forms of human SH3P2, lysed, and subjected to 
immunoprecipitation (IP) with antibodies to GFP. The result-
ing precipitates as well as the whole-cell lysates (10% of the 
input for immunoprecipitation) were subjected to immunoblot 
analysis with antibodies to Myo1E and to GFP. Amino acid 
sequences of the PR region and the C-terminal acidic amino 
acid cluster are shown. The RSK phosphorylation site (Ser202), 
acidic amino acids, basic amino acids, and proline are indi-
cated in yellow, red, blue, and green, respectively. All data 
are representative of at least three separate experiments.
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This serine residue is located in the C-terminal region of SH3P2, 
which is required for the interaction with Myo1E (Fig. 2 B). We 
therefore examined whether RSK-mediated phosphorylation of 
SH3P2 affects its interaction with Myo1E.
Coimmunoprecipitation assays with antibodies to SH3P2 
and to Myo1E revealed an inverse relation between the extent 
of SH3P2 phosphorylation (resulting from ERK pathway acti-
vation) and the extent of SH3P2 interaction with Myo1E in sev-
eral tumor cell lines (Fig. 4 A). Marked association of these two 
proteins was thus observed in HeLa S3 (78.7 ± 11.6% of Myo1E 
in cell lysates was associated with SH3P2) and MKN1 (78.4 ± 
6.8%) cells, in which the activity of the ERK pathway is limited 
(Hoshino et al., 1999). Stimulation of these cells with serum, 
however, induced SH3P2 phosphorylation and reduced the level 
Figure 3. Myo1E interacts with SH3P2 via its SH3 domain and the C-terminal positively charged region of its TH2 domain. (A) Glutathione-Sepharose 
beads coupled with GST-fused human Myo1E(SH3) were incubated with recombinant human SH3P2 or SH3P2(ΔPR), after which bead-bound proteins as 
well as recombinant SH3P2 or SH3P2(ΔPR) (10% of the input for the pull-down assay) were subjected to SDS-PAGE followed by staining with Coomassie 
brilliant blue (CBB) or immunoblot analysis (IB) with antibodies to SH3P2. (B) MKN1 cells were transfected for 24 h with vectors encoding EGFP-tagged 
wild-type or indicated mutant forms of human Myo1E, lysed, and subjected to immunoprecipitation (IP) with antibodies to GFP. The resulting precipitates as 
well as the whole-cell lysates (10% of the input for immunoprecipitation) were subjected to immunoblot analysis with antibodies to SH3P2 and to GFP. The 
amino acid sequence of the C-terminal positively charged region of the TH2 domain of Myo1E is shown, with acidic amino acids, basic amino acids, and 
proline being indicated in red, blue, and green, respectively. (C) MKN1 cells were transfected for 24 h with vectors encoding EGFP-tagged wild-type or 
mutant forms of human Myo1E, lysed, and subjected to pull-down assays with GST or GST-fused wild-type or mutant forms of human SH3P2. Bead-bound 
proteins as well as the whole-cell lysates (10% of the input for the pull-down assays) were subjected to SDS-PAGE followed by staining with Coomassie 
brilliant blue or by immunoblot analysis with antibodies to GFP. All data are representative of at least three separate experiments.
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of SH3P2–Myo1E interaction within 10 min (22.4 ± 3.9% in 
MKN1 cells); both of these effects were partially reversed at 120 
min after the onset of stimulation, and they were prevented by 
prior exposure of the cells to PD184352, an inhibitor of the ERK 
kinase MEK. In contrast, only a low level of SH3P2–Myo1E in-
teraction (6.1 ± 2.1%) was apparent in MDA-MB-231 cells, in 
which the ERK pathway is constitutively activated (Hoshino et 
al., 1999), and treatment of these cells with PD184352 induced 
dephosphorylation of SH3P2 and increased the association be-
tween these two proteins (17.1 ± 4.0%).
The unphosphorylatable mutant SH3P2(S202A) showed 
marked association with Myo1E in HeLa S3 cells, and 
serum stimulation of these cells did not induce the dissocia-
tion of Myo1E from SH3P2(S202A) (Fig. 4 B). Furthermore, 
SH3P2(S202A), but not wild-type SH3P2, also showed a high 
level of association with Myo1E in MDA-MB-231 and HT-1080 
cells, in the latter of which the ERK pathway is also constitu-
tively activated (Hoshino et al., 1999). Finally, serum-induced 
cell motility in MKN1 and HeLa S3 cells and the enhanced 
basal level of motility in MDA-MB-231 cells were markedly 
attenuated by PD184352 (Fig. 4 C). Together, these results in-
dicated that RSK-mediated phosphorylation of SH3P2 at Ser202 
induces the dissociation of Myo1E from SH3P2, with this dis-
sociation being required for the induction of cell motility.
Myo1E localizes to lamellipodial tips after 
dissociation from SH3P2
Both Myo1E and SH3P2 were localized to the cytosol of se-
rum-deprived MKN1 cells (Fig. 5, A and B). Serum stimulation 
of the cells induced rapid translocation of Myo1E to sites of 
actin polymerization in lamellipodia, which define the tips of 
these structures (Fig. 5 A), whereas it had no substantial effect 
on the subcellular localization of SH3P2 (Fig. 5 B).
Activation of both the ERK and PI3K signaling pathways 
is required for the induction of actin polymerization and subse-
quent lamellipodium formation (Wennström et al., 1994; Weiger 
et al., 2009; Mendoza et al., 2011; Vanhaesebroeck et al., 2012). 
Prior treatment of MKN1 cells with PD184352 thus inhibited 
the serum-induced formation of lamellipodia and suppressed 
the translocation of Myo1E to the plasma membrane (Fig. 5 A). 
Figure 4. RSK-mediated phosphorylation of SH3P2 at Ser202 induces the dissociation of Myo1E from SH3P2. (A) MKN1 or HeLa S3 cells were deprived 
of serum for 12 h, incubated with or without 10 µM PD184352 for 30 min, and then stimulated with 10% FBS for the indicated times. Exponentially 
growing MDA-MB-231 cells were incubated with or without 10 µM PD184352 for 4 h. Cell lysates were then subjected to immunoprecipitation (IP) with 
antibodies to SH3P2 or to Myo1E, and the resulting precipitates as well as the whole-cell lysates (10% of the input for immunoprecipitation) were subjected 
to immunoblot analysis (IB) with antibodies to the indicated proteins. (B) HeLa S3, MDA-MB-231, or HT-1080 cells were transfected for 24 h with vectors 
for EGFP-SH3P2 or EGFP-SH3P2(S202A), and the transfected HeLa S3 cells were then deprived of serum for 12 h before stimulation with 10% FBS for 10 
min. Cell lysates were subjected to immunoprecipitation with antibodies to Myo1E, and the resulting precipitates as well as the whole-cell lysates (10% 
of the input for immunoprecipitation) were subjected to immunoblot analysis with antibodies to the indicated proteins. (C) The motility of MKN1, HeLa 
S3, or MDA-MB-231 cells was measured with a transwell migration assay for 6 h in the absence or presence of 10% FBS, 10 µM PD184352, or 10 µM 
LY294002 as indicated. The numbers of cells that had migrated to reach the lower surface of the filter were 212 ± 20, 63 ± 14, and 177 ± 26 for FBS-stim-
ulated MKN1, HeLa S3, and MDA-MB-231 cells, respectively. Data are representative of at least three separate experiments (A and B) or are means ± SD 
for three separate experiments (C). **, P < 0.01 versus FBS-stimulated cells.
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Furthermore, the PI3K inhibitor LY294002 suppressed the se-
rum-induced production of PI(3,4,5)P3 (Fig. S3 A), lamellipo-
dium formation, translocation of Myo1E to the cell periphery 
(Fig. 5 A), and cell motility (Fig. 4 C). In addition, exponen-
tially growing MDA-MB-231 cells exhibited lamellipodia at 
their periphery in which F-actin and Myo1E were colocalized, 
and PD184352 treatment of the cells induced a marked reduc-
tion in the extent of lamellipodium formation and abolished the 
association of Myo1E with lamellipodial tips (Fig.  5  A). Fi-
nally, a low concentration of latrunculin A, which inhibits actin 
assembly through sequestration of monomeric actin, also sup-
pressed translocation of Myo1E to the cell periphery in MKN1 
cells (Fig. 5 C), suggesting that serum-induced rearrangement 
of F-actin, rather than the production of PI(3,4,5)P3, is critical 
for localization of Myo1E to the plasma membrane.
Subcellular fractionation confirmed that most Myo1E and 
almost all SH3P2 resided in the cytosolic fraction of resting 
MKN1 cells, that serum stimulation induced the translocation 
of a substantial proportion (∼10%) of Myo1E to the mem-
brane fraction without affecting the cytosolic localization of 
SH3P2, and that the serum-induced association of Myo1E with 
the membrane fraction was suppressed by PD184352 and by 
LY294002 (Figs. 5 D and S3 B). These results suggested that 
after its dissociation from SH3P2, Myo1E translocates from the 
cytosol to the tips of lamellipodia via binding to F-actin.
Role of the TH2 domain in the localization 
of Myo1E to lamellipodial tips
To examine how Myo1E interacts with the plasma mem-
brane, we determined the localization of EGFP-tagged Myo1E 
and its deletion mutants in transfected MKN1 cells. Serum 
stimulation of the cells induced the formation of lamellipo-
dia (Fig.  5  A), to which wild-type Myo1E, Myo1E(ΔSH3), 
and Myo1E(ΔTH2-b2/SH3), but not Myo1E(ΔTH2/SH3) 
or Myo1E(ΔTH1/TH2/SH3), were found to be localized 
(Fig.  6  A). Myo1E(ΔTH2-b2/SH3) thus colocalized with F- 
actin at extended lamellipodial tips, whereas Myo1E(ΔTH2/
SH3) did not (Fig. 6 B). Although lamellipodia were less well 
defined in cells expressing a mutant of Myo1E lacking the 
motor head domain (Myo1E(ΔMotor)) than in those expressing 
the wild-type protein, localization of this mutant to the periph-
ery of serum-stimulated cells was observed (Fig. 6 A).
Subcellular fractionation revealed that EGFP-tagged 
Myo1E and its deletion mutants as well as β-actin were detected 
in both cytosolic and membrane fractions of transfected MKN1 
cells under exponentially growing conditions, although the pro-
portion of each Myo1E protein in the membrane fraction varied 
(Fig. 6 C). The proportion of Myo1E mutants lacking all or most 
of the TH2 domain (Myo1E(ΔTH2/SH3) and Myo1E(ΔTH1/
TH2/SH3)) in the membrane fraction was thus reduced compared 
with that for wild-type Myo1E or deletion mutants containing 
all or most of the TH2 domain (Myo1E(ΔSH3), Myo1E(ΔMo-
tor), Myo1E(ΔTH2-b1/SH3), and Myo1E(ΔTH2-b2/SH3)). 
Figure 5. Myo1E localizes to lamellipodial tips after dissociation from 
SH3P2. (A–C) MKN1 cells deprived of serum for 12  h were incubated 
with or without 10 µM PD184352 (PD18), 10 µM LY294002 (LY29), or 
50 nM latrunculin A (Lat A) for 30 min and then stimulated with 10% 
FBS for 10 min. Exponentially growing MDA-MB-231 cells were incubated 
with or without 10 µM PD184352 for 4 h. All cells were then fixed and 
stained with antibodies to Myo1E (A and C, green) or to SH3P2 (B, green) 
as well as with phalloidin (A–C, magenta). Green arrowheads indicate 
Myo1E colocalized with F-actin, whereas magenta arrowheads indicate 
lamellipodia. Bars, 10 µm. The percentages of cells in which Myo1E and 
F-actin were colocalized are shown at the right of the merged images as 
means ± SD for three separate experiments, with n ≥ 80 (A) or 40 (C) cells 
in each experiment. Fluorescence intensity profiles along the white lines in 
the merged images are also shown on the right (a.u., arbitrary units). Data 
are representative of at least three separate experiments. (D) MKN1 cells 
deprived of serum for 12 h were incubated with or without PD184352 or 
LY294002 for 30 min and then stimulated with 10% FBS for 10 min. The 
cells were then subjected to subcellular fractionation, and 20% of the cyto-
solic fraction and 50% of the membrane fraction were subjected to immu-
noblot analysis (IB) with antibodies to the indicated proteins (left). α-Tubulin 
was analyzed as a cytosolic marker and CD44, MMP-14, and integrin β1 
as membrane markers. The proportion of Myo1E in the membrane fraction 
was determined by measurement of immunoblot signals as mean ± SD 
values for three separate experiments (right). *, P < 0.05; **, P < 0.01.
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Together with the previous demonstration that the TH2 domain 
of Myo1E preferentially associates with dynamic F-actin (Yu 
and Bement, 2007), these results suggested that after its disso-
ciation from SH3P2, Myo1E localizes to lamellipodial tips in a 
manner dependent on interaction between the TH2 domain and 
F-actin. However, the C-terminal positively charged region of 
the TH2 domain, which mediates the interaction of Myo1E with 
SH3P2 (Fig. 3), does not appear to be required for the associa-
tion of Myo1E with F-actin.
SH3P2 suppresses the localization of 
Myo1E to lamellipodial tips
We further examined the physiological relevance of the SH3P2–
Myo1E interaction. Forced expression of wild-type SH3P2 or 
SH3P2(S202A), but not that of an SH3P2 mutant lacking the 
Myo1E binding regions (SH3P2(ΔPR/C)), prevented the mem-
brane association of Myo1E in MKN1 cells (Fig. 7 A). Incuba-
tion of a membrane fraction of MKN1 cells with recombinant 
Myo1E in vitro confirmed that the membrane association of 
Myo1E was suppressed by prior incubation with GST-SH3P2 
in a concentration-dependent manner, but not by that with GST-
SH3P2(ΔPR/C) (Fig. S4).
Forced expression of SH3P2 also suppressed the mem-
brane association of Myo1E(ΔSH3), which interacts with 
SH3P2, but not that of Myo1E(ΔTH2-b2/SH3), which does 
not interact with SH3P2 (Fig. 7 B). RNAi-mediated depletion 
of SH3P2 increased the association of Myo1E with the mem-
brane fraction even under resting conditions, and the extent of 
this association was not increased further by serum stimulation 
of the cells (Fig. 7 C). Knockdown of SH3P2 with an siRNA 
targeting the 5′-UTR sequence also increased the association 
of Myo1E with the membrane fraction, and this effect was 
Figure 6. The TH2 domain mediates the localization of Myo1E to lamellipodial tips. (A and B) MKN1 cells were transfected for 24 h with vectors for the 
indicated EGFP-tagged Myo1E constructs, deprived of serum for 12 h, and then stimulated with 10% FBS for 10 min. The cells were fixed and then exam-
ined for EGFP fluorescence (B, green) with or without staining with phalloidin (B, magenta). White arrowheads (A) indicate Myo1E proteins localized to 
lamellipodial tips, whereas green and magenta arrowheads (B) indicate colocalization of Myo1E and F-actin, respectively, at lamellipodial tips. Bars, 10 
µm. The percentages of cells in which EGFP-Myo1E proteins were localized to lamellipodial tips (A) or colocalized with F-actin (B) are shown at the right 
of the images as means ± SD for three separate experiments, with n ≥ 80 (A) or 30 (B) cells in each experiment. Fluorescence intensity profiles along the 
white lines are also shown on the right. Data are representative of at least three separate experiments. (C) MKN1 cells transfected for 24 h with vectors 
for the indicated EGFP-Myo1E constructs were subjected to subcellular fractionation, and 20% of the cytosolic (C) fraction and 50% of the membrane (M) 
fraction were subjected to immunoblot analysis (IB) with antibodies to the indicated proteins (top). The proportion of each EGFP-Myo1E construct in the 
membrane fraction was determined by measurement of immunoblot signals as mean ± SD values for three separate experiments (bottom). *, P < 0.05.
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Figure 7. SH3P2 suppresses the localization of Myo1E to lamellipodial tips. (A and B) MKN1 cells transfected for 24 h with vectors for EGFP-Myo1E and the 
indicated EGFP-SH3P2 constructs (WT, wild type; A) or for FLAG-tagged SH3P2 and the indicated EGFP-Myo1E constructs (B) were subjected to subcellular frac-
tionation, and 20% of the cytosolic (C) fraction and 50% of the membrane (M) fraction were subjected to immunoblot analysis (IB) with antibodies to the indicated 
proteins (top). The proportion of EGFP-Myo1E constructs in the membrane fraction was determined by measurement of immunoblot intensities as mean ± SD values 
for three separate experiments (bottom). *, P < 0.05; **, P < 0.01. (C) MKN1 cells transfected with an SH3P2 siRNA (#449 or #500) or a control siRNA for 48 h 
were deprived of serum for 12 h and then stimulated with 10% FBS for 10 min. The cells were then subjected to subcellular fractionation followed by quantitative 
immunoblot analysis, and the proportion of Myo1E in the membrane fraction was determined, as in A and B. (D) MKN1 cells were transfected first with an siRNA 
targeting the 5′-UTR sequence of SH3P2 (#36) or a control siRNA for 48 h and then with vectors for EGFP-Myo1E and FLAG-SH3P2 for 24 h. The cells were 
subjected to subcellular fractionation followed by quantitative immunoblot analysis, and the proportion of EGFP-Myo1E in the membrane fraction was determined 
as in A and B. Open and closed arrowheads indicate FLAG-SH3P2 and endogenous SH3P2 bands, respectively. (E) MKN1 cells transfected with vectors for EGFP- 
SH3P2(S202A) or EGFP-SH3P2(ΔPR/C) for 24 h were deprived of serum for 12 h, stimulated with 10% FBS for 10 min, fixed, and stained with antibodies to 
Myo1E (red) and with phalloidin (blue). EGFP fluorescence was monitored directly. Red arrowheads indicate Myo1E localized to lamellipodial tips, blue arrowheads 
indicate lamellipodia, and white arrows indicate cells expressing EGFP-SH3P2(S202A) or EGFP-SH3P2(ΔPR/C). Bar, 20 µm. The percentages of EGFP-positive 
cells in which Myo1E and F-actin were colocalized are shown below the merged images as means ± SD for three separate experiments, with n ≥ 40 cells in each 
experiment. Fluorescence intensity profiles along the white lines in the merged images are also shown. Data are representative of at least three separate experiments.
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suppressed by forced expression of SH3P2 (Fig. 7 D). Finally, 
whereas expression of SH3P2(S202A) attenuated the serum- 
induced localization of Myo1E to lamellipodial tips, expression 
of SH3P2(ΔPR/C) did not (Fig.  7  E). Together, these results 
suggested that SH3P2 functions as a cytoplasmic anchor for 
Myo1E to suppress its localization to lamellipodial tips.
Myo1E promotes active lamellipodium 
formation and thereby increases 
cell motility
RNAi-mediated depletion of SH3P2 increased the motility of 
MKN1 cells as revealed by both wound-healing and transwell 
migration assays (Fig. 8 A). In contrast, RNAi-mediated knock-
down of Myo1E suppressed motility in MKN1, MDA-MB-231, 
and HT-1080 cells (Fig. 8 B). Knockdown of Myo1E by itself 
with an siRNA targeting the ORF (Fig. 8 C) or the 5′-UTR se-
quence (Fig. 8 D) did not abolish the serum-induced formation 
of lamellipodia in MKN1 cells. However, lamellipodia formed 
under such conditions were poorly developed compared with 
those formed in cells transfected with a control siRNA. Im-
portantly, forced expression of EGFP-Myo1E restored the 
formation of extended lamellipodia in cells depleted of endog-
enous Myo1E with the siRNA targeting the 5′-UTR sequence 
(Fig. 8 D). Furthermore, rescue of Myo1E expression by infec-
tion with a lentivirus encoding FLAG epitope–tagged Myo1E 
restored the motility of Myo1E-depleted MKN1 cells (Fig. 8 E). 
Together, these results suggest that Myo1E is necessary for the 
formation of active lamellipodia required for cell motility.
Discussion
The molecular mechanisms underlying cell motility, especially 
with regard to the integration of signaling pathways and cyto-
skeletal systems, remain poorly understood. Activation of both 
the PI3K and ERK pathways downstream of Ras is essential 
for the induction of cell motility. We recently identified SH3P2 
as a negative regulator of cell motility whose function is inhib-
ited by RSK-mediated phosphorylation (Tanimura et al., 2011). 
We have now identified Myo1E as a binding partner of SH3P2 
and uncovered the molecular mechanism by which SH3P2 
inhibits cell motility.
We first examined how SH3P2 interacts with Myo1E with 
the use of pull-down assays with GST-fused SH3P2 or Myo1E 
deletion mutants as baits as well as coimmunoprecipitation as-
says with MKN1 cells expressing such deletion mutants tagged 
with EGFP. Our results suggest that SH3P2 interacts with 
Myo1E in the cytosol through two binding interfaces. The PR 
region of SH3P2 thus interacts with the SH3 domain of Myo1E, 
and the C-terminal acidic amino acid cluster of SH3P2 interacts 
with the positively charged region located at the C terminus of 
the TH2 domain of Myo1E (Fig. 9, 1a). We confirmed that the 
SH3 domain of Myo1E interacts directly with SH3P2 in a man-
ner dependent on the PR region of SH3P2. However, we failed 
to demonstrate direct interaction between the TH2 domain of 
Myo1E and SH3P2 or between the C-terminal acidic amino 
acid cluster of SH3P2 and Myo1E, possibly because such small 
domains of SH3P2 and Myo1E alone are not able to maintain 
their native conformations when expressed as EGFP-tagged or 
GST-fused constructs. Structural analysis of the SH3P2–Myo1E 
complex will be required to provide a full understanding of the 
mode of interaction between these two proteins.
Serum stimulation of cells induces activation of the 
ERK signaling pathway and the consequent phosphorylation 
of SH3P2 at Ser202 by RSK, resulting in the dissociation of 
Myo1E from SH3P2 (Fig.  9, step 2). Free Myo1E binds di-
rectly to membranes via association of its TH1 domain with 
anionic phospholipids such as PI(4,5)P2 and PI(3,4,5)P3, with 
such interactions being relatively nonspecific and electrostatic 
in nature rather than stereospecific (Feeser et al., 2010). We 
have now shown that the TH2 domain is required for the pref-
erential localization of Myo1E to lamellipodial tips via binding 
to F-actin. This domain was previously shown to be required 
for the localization of Myo1E to invadosomes (Ouderkirk and 
Krendel, 2014). Long-tailed class 1 myosins bind to F-actin via 
the TH2 domain as well as the motor domain (Doberstein and 
Pollard, 1992; Jung and Hammer, 1994; Rosenfeld and Rener, 
1994). Furthermore, the TH2 domain was shown to mediate the 
targeting of Xenopus laevis Myo1E to newly assembled actin in 
vivo (Yu and Bement, 2007) and to be required for the targeting 
of Myo1B to dynamic actin waves in Dictyostelium discoideum 
(Brzeska et al., 2014). The binding of the TH2 domain to F- 
actin thus provides a mechanism by which this class of myosin 
can be targeted specifically to sites of active actin assembly. To-
gether, these previous and our present observations suggest that 
the TH2 domain plays a key role in the localization of Myo1E 
to lamellipodial tips through its binding to F-actin, whereas the 
TH1 domain may facilitate the association of Myo1E with the 
plasma membrane by binding to anionic phospholipids.
Myo1E localized at the plasma membrane interacts with 
F-actin to generate mechanical force and thereby regulates 
plasma membrane tension (McConnell and Tyska, 2010). 
Myo1E has also been shown to transport or recruit several 
effector molecules such as dynamin, synaptojanin-1, and the 
N-WASP–WIP complex to the membrane–cytoskeleton inter-
face in a process dependent on the binding of the PR region 
of the respective cargo to the SH3 domain of Myo1E (Kren-
del et al., 2007; Cheng et al., 2012; Gupta et al., 2013). The 
TH2 domain of Myo1E also contains three conserved PR re-
gions (Fig. S1 B), through which Myo1E might bind to SH3 
domain–containing proteins and transport or recruit them to 
the plasma membrane. These observations suggest that the me-
chanical force generated by Myo1E–F-actin interaction at the 
plasma membrane together with the functions of effector mole-
cules transported or recruited by Myo1E through binding to its 
SH3 domain and possibly to its TH2 domain coordinately in-
duce active lamellipodium formation and thereby promote cell 
migration (Fig. 9, step 3).
Given that SH3P2 also binds to the SH3 domain of Myo1E 
via its PR region, SH3P2 may regulate the interaction of PR 
region–containing effector molecules with Myo1E in a compet-
itive manner. In this regard, deletion of its SH3 domain did not 
affect the binding of Myo1E to SH3P2 in MKN1 cells. The SH3 
domain of most Myo1E molecules in these cells may be occu-
pied by effector proteins rather than by SH3P2. Thus, although 
SH3P2 is able to bind to Myo1E through the two binding in-
terfaces identified in the present study, the interaction between 
the C-terminal acidic amino acid cluster of SH3P2 and the pos-
itively charged region at the C terminus of the TH2 domain of 
Myo1E may be responsible for the association of the two pro-
teins in most SH3P2–Myo1E complexes in cells (Fig. 9, 1b).
The major finding of the present study is that SH3P2 
regulates the intracellular localization of Myo1E in an ERK 
pathway–dependent manner. The cytosolic protein SH3P2 thus 
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Figure 8. Myo1E facilitates lamellipodium formation and thereby promotes cell motility. (A) MKN1 cells transfected with an SH3P2 siRNA (#449 or #500) 
or a control siRNA were subjected to a wound-healing assay (top and bottom left panels) or a transwell migration assay (bottom right panel) in the presence 
of 10% FBS for 8 or 6 h, respectively. Bar, 100 µm. The number of cells that had migrated to reach the lower surface of the filter in the transwell migration 
assay was 98 ± 7 for cells transfected with the control siRNA (bottom right panel). Quantitative data are means ± SD for three separate experiments. **, 
P < 0.01 versus cells transfected with the control siRNA. (B) MKN1, MDA-MB-231, and HT-1080 cells transfected with a Myo1E siRNA (#1 or #2) or a 
control siRNA were subjected to a transwell migration assay in the presence of 10% FBS for 6 h. Cell lysates were also subjected to immunoblot analysis 
(IB) with antibodies to Myo1E and to β-actin (loading control). The numbers of cells that had migrated to reach the lower surface of the filter were 159 ± 
17, 166 ± 15, and 288 ± 12 for control siRNA–transfected MKN1, MDA-MB-231, and HT-1080 cells, respectively. Quantitative data are means ± SD 
for three separate experiments. **, P < 0.01 versus cells transfected with the control siRNA. (C) MKN1 cells transfected with a Myo1E siRNA (#1 or #2) 
or a control siRNA for 48 h were deprived of serum for 12 h, stimulated with 10% FBS for 10 min, fixed, and stained with antibodies to Myo1E and with 
phalloidin. Green arrowheads indicate Myo1E localized to lamellipodial tips, magenta arrowheads indicate extended lamellipodia (total length of >50 
µm per cell), and yellow arrowheads indicate immature lamellipodial structures (total length of <50 µm per cell). Bar, 20 µm. The percentages of cells with 
extended lamellipodia are shown below the images as means ± SD for three separate experiments, with n ≥ 60 cells in each experiment. (D) MKN1 cells 
were transfected first with an siRNA targeting the 5′-UTR sequence of Myo1E (#3) for 48 h and then with a vector for EGFP or EGFP-Myo1E for 24 h. The 
cells were then deprived of serum for 12 h, stimulated with 10% FBS for 10 min, fixed, and examined for EGFP fluorescence and stained with phalloidin. 
Green arrowheads indicate Myo1E localized to lamellipodial tips, magenta arrowheads indicate extended lamellipodia (total length of >50 µm per cell), 
yellow arrowheads indicate immature lamellipodial structures (total length of <50 µm per cell), and white arrows indicate cells positive for EGFP or EGFP- 
Myo1E. Bar, 20 µm. The percentages of EGFP-positive cells with extended lamellipodia are shown below the images as means ± SD for three separate 
experiments, with n ≥ 40 cells in each experiment. Cell lysates were also subjected to immunoblot analysis with antibodies to Myo1E and to β-actin. Data 
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forms a complex with most Myo1E to prevent its localization 
to the plasma membrane in cells in which basal ERK activity 
is limited. On cell stimulation, however, activated RSK1 phos-
phorylates SH3P2 at Ser202 and thereby induces the dissocia-
tion of Myo1E from SH3P2 and the subsequent translocation of 
Myo1E to the tips of lamellipodia, a process that is essential for 
the induction of cell motility. Binding of SH3P2 likely renders 
Myo1E inaccessible to F-actin and possibly to effector mole-
cules, thereby preventing Myo1E localization to lamellipodial 
tips. SH3P2 therefore functions as a cytoplasmic anchor for 
Myo1E and thereby negatively regulates cell motility.
Activation of the PI3K and ERK signaling pathways by 
serum stimulation results in the production of PI(3,4,5)P3 and 
consequent F-actin rearrangement at the leading edge of the 
cell as well as in phosphorylation of SH3P2 and consequent 
dissociation of Myo1E, respectively. The ERK pathway also 
contributes to the rearrangement of F-actin via ERK-medi-
ated phosphorylation of WAVE2 and Abi1, components of the 
WAVE2 regulatory complex (Mendoza et al., 2011). Myo1E 
thus appears to be positioned at an integration point for the ERK 
and PI3K pathways in the coordinated regulation of cell motil-
ity, with Myo1E released from its cytoplasmic anchor SH3P2 
moving along the rearranged actin filaments toward the leading 
edge of the cell. Myo1E thereby localized at lamellipodial tips, 
and the effector molecules recruited by binding to its SH3 do-
main then cooperatively promote lamellipodium extension and 
consequent cell migration. Further studies are required to de-
termine the precise molecular mechanisms by which the down-
stream targets of Myo1E facilitate cell motility.
Materials and methods
Antibodies and reagents
Rabbit polyclonal antibodies to SH3P2 and to Ser202-phosphorylated 
SH3P2 were prepared as described previously (Tanimura et al., 2011). 
Rabbit polyclonal antibodies to Myo1E were generated in response to a 
GST fusion protein containing the SH3 domain of human Myo1E (amino 
acids 1,039–1,108) and were purified with an affinity column contain-
ing the His6-tagged antigen. Antibodies to ERK1/2, RSK1, Sam68, and 
hnRNP-K were obtained from Santa Cruz Biotechnology, Inc.; those 
to GFP (mouse/rat) were obtained from Nacalai Tesque; those to di-
phosphorylated ERK1/2, α-tubulin, FLAG, and β-actin were obtained 
from Sigma-Aldrich; those to Akt and Ser473-phosphorylated Akt were 
obtained from Cell Signaling Technology; those to integrin β1 (CD29) 
were obtained from BD; those to MMP-14 (MT1-MMP) were obtained 
from EMD Millipore; and those to CD44 were obtained from R&D 
Systems. PD184352 was synthesized as described previously (Tani-
mura et al., 2003), LY294002 was obtained from Wako Pure Chemical 
Industries, and latrunculin A was obtained from Cayman Chemical.
Cell culture and migration assays
The human tumor cell lines MKN1, HT-1080 (Health Science Research 
Resources Bank), HeLa S3, and MDA-MB-231 (ATCC) were cultured 
in DMEM supplemented with 10% FBS. Cell motility was analyzed 
with a transwell migration assay as described previously (Tanimura et 
al., 2011) as well as with a wound-healing assay. In the latter, a scratch 
wound was introduced in a monolayer of MKN1 cells with a plastic 
micropipette tip. After incubation for 8 h to allow wound healing, cells 
were fixed with 100% methanol and stained with Coomassie brilliant 
blue. Images were acquired with an Axiovert 200M microscope (ZEI 
SS) equipped with an AxioCam MRm camera (ZEI SS), and the width 
of the wound area was measured with the use of AxioVision soft-
ware version 4.8.2 (ZEI SS).
Subcellular fractionation
Subcellular fractionation of MKN1 cells was performed as described 
previously (Higuchi et al., 2008), with minor modifications. In brief, 
cells grown in each well of a 12-well plate were scraped into 200 µl 
hypotonic lysis buffer (25 mM Tris-HCl, pH 7.4, 25 mM NaCl, 1 mM 
sodium orthovanadate, 10  mM NaF, 10  mM sodium pyrophosphate, 
25 mM β-glycerophosphate, 25 mM p-nitrophenyl phosphate, 20 nM 
okadaic acid, 0.2 mM sodium molybdate, 0.5 mM EGTA, 1 mM PMSF, 
10 µg/ml leupeptin, and 10 µg/ml aprotinin; Hoshino et al., 1999) and 
disrupted with the use of a Dounce homogenizer. The homogenate was 
centrifuged at 700 g for 5 min at 4°C to remove nuclei and intact cells, 
and the resulting supernatant was centrifuged at 20,000 g for 30 min at 
4°C to obtain a cytosolic fraction (supernatant) and pellet. After wash-
ing with the hypotonic lysis buffer, the pellet was suspended in 100 µl 
of the hypotonic lysis buffer containing 1% Triton X-100 and centri-
fuged at 20,000  g for 30 min at 4°C to obtain a membrane fraction 
(supernatant). Portions corresponding to 20% or 50% of the cytosolic 
or membrane fractions, respectively, prepared from cells grown in each 
well of a 12-well plate were analyzed for the distribution of Myo1E.
Cell lysis and immunoblot analysis
Cell lysates were prepared with a solution containing 25 mM Tris-HCl, 
pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM sodium orthovanadate, 
10 mM NaF, 10 mM sodium pyrophosphate, 25 mM β-glycerophos-
phate, 25 mM p-nitrophenyl phosphate, 20 nM okadaic acid, 0.2 mM 
sodium molybdate, 0.5 mM EGTA, 1 mM PMSF, 10 µg/ml leupeptin, 
and 10 µg/ml aprotinin. Cell lysates were fractionated by SDS-PAGE, 
and the separated proteins were transferred electrophoretically to a 
polyvinylidene difluoride membrane and probed with primary anti-
bodies and HRP-conjugated secondary antibodies (Promega). Immune 
complexes were detected with the use of enhanced chemiluminescence 
reagents (GE Healthcare) and an ImageQuant LAS4000 instrument 
(GE Healthcare). Image analysis was performed with National Insti-
tutes of Health ImageJ version 1.46r software. For quantitation of im-
munoblot signals, linearity of band intensities was examined with the 
use of serial dilutions of each sample and the intensity of each band 
was measured within the linear range of detection (Janes, 2015). Rep-
resentative results of such quantitation for the distribution of Myo1E, 
CD44, integrin β1, and MMP-14 in cytosolic and membrane fractions 
of MKN1 cells are shown in Fig. S5.
Coimmunoprecipitation analysis
Cell lysates were incubated with antibodies for 6 h at 4°C with gentle 
shaking. Immune complexes were precipitated with Protein A/G PLU S 
Agarose (Santa Cruz Biotechnology, Inc.), washed three times with cell 
are representative of at least three separate experiments. (E) MKN1 cells were transfected with an siRNA targeting the 5′-UTR sequence of Myo1E (#3) for 
24 h, infected with lentiviruses encoding GFP or Myo1E-FLAG for 24 h, and then cultured in fresh medium for 24 h. The cells were subjected to a transwell 
migration assay in the presence of 10% FBS for 6 h. Cell lysates were also subjected to immunoblot analysis with antibodies to the indicated proteins. The 
number of cells that had migrated to reach the lower surface of the filter was 205 ± 15 for control siRNA–transfected MKN1 cells. Quantitative data are 
means ± SD for three separate experiments. **, P < 0.01.
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lysis buffer, and then subjected to SDS-PAGE followed by either stain-
ing with Coomassie brilliant blue or immunoblot analysis. The propor-
tion of Myo1E associated with SH3P2 was calculated by comparison 
of the intensity of the SH3P2 and Myo1E bands in immunoprecipitates 
prepared with antibodies to these proteins with that of those in the cor-
responding cell lysates.
GST pull-down assays
Bacterially expressed GST, GST-fused wild-type or mutant forms 
of SH3P2, or GST-Myo1E(SH3) (10 µg for each) bound to glutathi-
one-Sepharose beads (GE Healthcare) was incubated with gentle 
shaking for 6 h at 4°C with MKN1 cell lysate or recombinant SH3P2 
or SH3P2(ΔPR). The bead-bound proteins were then subjected to 
SDS-PAGE followed by either staining with Coomassie brilliant blue 
or immunoblot analysis.
Plasmids
The mammalian expression vectors pEGFP-C1-SH3P2 and pEGFP-
C1-SH3P2(S202A) were generated as described previously (Tanimura 
et al., 2011). For generation of expression plasmids encoding human 
SH3P2 amino acids 1 to 189 (ΔC), 1 to 204 (ΔC1), 1 to 208 (ΔC2), 
44 to 214 (ΔPR/SH3), or 12 to 189 (ΔPR/C), the corresponding cDNA 
fragments were amplified from wild-type SH3P2 cDNA by PCR with 
the primer pairs (forward with the underlined EcoRI site and reverse 
with the underlined XhoI site, respectively) 5′-CGGAA TTCGAT GTC 
GAA GCC GCC ACCC-3′ and 5′-GCCCTC GAGTTA CAG CAG AGA 
TGC ACA GGC-3′, 5′-CGGAA TTCGAT GTC GAA GCC GCC ACCC-3′ 
and 5′-GCCCTC GAGTTA GGC ATT GCT TAA TGT TC-3′, 5′-CGGAA 
TTCGAT GTC GAA GCC GCC ACCC-3′ and 5′-GCCCTC GAGTTA 
GAG ATA GTC CTC GGC AT-3′, 5′-CCGAA TTCCAT GAG CGA TAC 
CAA TTGG-3′ and 5′-GCCCTC GAGTTA ATC TGA GTC TTC ATC-3′, 
and 5′-CCGAA TTCAGG GCA AGT TAA AGT CTTC-3′ and 5′-GCC 
CTC GAGTTA CAG CAG AGA TGC ACA GGC-3′, respectively. The 
PCR products were digested with EcoRI and XhoI, and the resulting 
fragments were cloned into EcoRI- and SalI-digested pEGFP-C1 (Ta-
kara Bio Inc.). For generation of an expression plasmid encoding FLAG-
tagged SH3P2, a cDNA fragment amplified from wild-type SH3P2 
cDNA by PCR with the primers (forward with the underlined EcoRI 
site and reverse with the underlined XhoI site, respectively) 5′-GCC 
GAA TTCGCG ATG TCG AAG CCG CCA CCC-3′ and 5′-GCCCTC 
GAGTTA ATC TGA GTC TTC ATC ATC-3′ was digested with EcoRI 
and XhoI and then cloned into EcoRI- and XhoI-digested pcDNA3 (In-
Figure 9. Model for the regulation of cell mo-
tility by the RSK-SH3P2-Myo1E axis. SH3P2 
binds to and functions as a cytosolic anchor 
for Myo1E (1). SH3P2 interacts with Myo1E 
through two binding interfaces (the PR region 
of SH3P2 with the SH3 domain of Myo1E, 
and the C-terminal acidic amino acid cluster 
of SH3P2 with the positively charged region 
located at the C terminus of the TH2 domain 
of Myo1E; 1a), with the latter interaction ap-
pearing to be responsible for the association 
of the two proteins in most SH3P2-Myo1E 
complexes in cells (1b). Serum stimulation of 
cells induces activation of the ERK signaling 
pathway and the consequent phosphorylation 
of SH3P2 at Ser202 by RSK, resulting in the 
dissociation of Myo1E from SH3P2 (2). Serum 
stimulation also induces activation of the PI3K 
signaling pathway, resulting in the production 
of PI(3,4,5)P3 and consequent rearrangement 
of F-actin at the leading edge of the cell. 
Myo1E released from SH3P2 moves along 
the rearranged actin filaments and localizes at 
the tips of lamellipodia via binding of its TH2 
domain to F-actin (3). The mechanical force 
generated by Myo1E–F-actin interaction at the 
plasma membrane together with the function 
of effector molecules transported or recruited 
by Myo1E through binding to its SH3 domain 
coordinately induce active lamellipodium for-
mation and thereby promote cell migration. 
PIP2, PI(4,5)P2; PIP3, PI(3,4,5)P3.
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vitrogen) together with the DNA sequence for an N-terminal FLAG 
tag. For construction of an expression plasmid encoding human 
Myo1E, a cDNA fragment was amplified from HeLa S3 cell cDNA by 
PCR with the forward primer 5′-GCCGGA TTCATG GGA AGC AAA 
GGT GTC-3′ (underline indicates the BamHI site) and reverse primer 
5′-GCCCTC GAGTCA GAT CTT GGT CAC ATAG-3′ (underline indi-
cates the XhoI site). The PCR product was digested either with BamHI 
and EcoRI to yield a cDNA encoding Myo1E amino acids 1 to 851 (N 
terminal) or with EcoRI and XhoI to yield a cDNA encoding Myo1E 
amino acids 852 to 1,108 (C terminal). The cDNA encoding N terminus 
was cloned into BglII- and EcoRI-digested pEGFP-C1, and that encod-
ing the C terminus was then cloned into the EcoRI- and SalI-digested 
pEGFP-C1 N terminus. For generation of expression plasmids encod-
ing human Myo1E amino acids 1 to 694 (ΔTH1/TH2/SH3) or 695 to 
1,108 (ΔMotor), the corresponding cDNA fragments were amplified 
from wild-type Myo1E cDNA by PCR with the primer pairs (forward 
with the underlined BamHI site and reverse with underlined XhoI site) 
5′-GCCGGA TTCATG GGA AGC AAA GGT GTC-3′ and 5′-GCCCTC 
GAGTCA CTT TCT CTC TCT CAT CTC-3′ for Myo1E(ΔTH1/TH2/
SH3) and 5′-GCCGGA TTCTAT GAT GGG TAT GCA CGA GTG ATA 
CAG-3′ and 5′-GCCCTC GAGTCA GAT CTT GGT CAC ATAG-3′ for 
Myo1E(ΔMotor). The PCR products were digested with BamHI and 
XhoI, and the resulting fragments were cloned into BglII- and SalI-di-
gested pEGFP-C1. For generation of expression plasmids encoding 
human Myo1E amino acids 1 to 1,050 (ΔSH3), 1 to 1,038 (ΔTH2-b1/
SH3), 1 to 1,020 (ΔTH2-b2/SH3), or 1 to 921 (ΔTH2/SH3), cDNA 
fragments corresponding to Myo1E amino acids 695 to 1,050, 695 to 
1,038, 695 to 1,020, or 695 to 921 were amplified from Myo1E(ΔMo-
tor) cDNA by PCR with the forward primer 5′-GCCGGA TTCTAT GAT 
GGG TAT GCA CGA GTG ATA CAG-3′ (underline indicates the BamHI 
site) and reverse primers 5′-GCCCTC GAGTCA CTT GGG CTT GGG 
CTG GGG-3′, 5′-GCCCTC GAGTCA TGG GGG AGG CCG ACT GG-3′, 
5′-GCCCTC GAGTCA GAC CTT GAG GAA ATCC-3′, or 5′-GCCCTC 
GAGTCA TCC GAT GCT GAC CTG CAG-3′ (underline indicates XhoI 
sites), respectively. The PCR products were digested with EcoRI and 
XhoI, and the resulting cDNA fragments corresponding to amino acids 
852 to 1,050, 852 to 1,038, 852 to 1,020, or 852 to 921 were cloned 
into the EcoRI- and SalI-digested pEGFP-C1 N terminus. For gener-
ation of an expression plasmid encoding human GRP1(PH), the cor-
responding cDNA fragment was amplified from HeLa S3 cell cDNA 
by PCR with the forward primer 5′-GCCGAA TTCGGA CGA CGG 
GAA CGA CCTG-3′ (underline indicates the EcoRI site) and reverse 
primer 5′-GCCCTC GAGCCT CGT TGC CAA CAT GTC-3′ (underline 
indicates the XhoI site). The PCR product was digested with EcoRI 
and XhoI and then cloned into EcoRI- and SalI-digested pEGFP-C1.
The bacterial expression vectors pGEX6P3-SH3P2 and 
pGEX6P3-SH3P2(ΔC) were generated as described previously (Tani-
mura et al., 2011). For generation of bacterial expression plasmids en-
coding human SH3P2 amino acids 12 to 214 (ΔPR), 44 to 214 (ΔPR/
SH3), 12 to 189 (ΔPR/C), or 12 to 71 (ΔPR/ANK/C), the correspond-
ing cDNA fragments were amplified from wild-type SH3P2 cDNA by 
PCR with the primer pairs (forward with the underlined EcoRI site 
and reverse with the underlined XhoI site, respectively) 5′-CCGAA 
TTCAGG GCA AGT TAA AGT CTTC-3′ and 5′-GCCCTC GAGTTA 
ATC TGA GTC TTC ATC-3′, 5′-CCGAA TTCCAT GAG CGA TAC CAA 
TTGG-3′ and 5′-GCCCTC GAGTTA ATC TGA GTC TTC ATC-3′, 5′-
CCGAA TTCAGG GCA AGT TAA AGT CTTC-3′ and 5′-GCCCTC 
GAGTTA CAG CAG AGA TGC ACA GGC-3′, and 5′-CCGAA TTCAGG 
GCA AGT TAA AGT CTTC-3′ and 5′-GCCCTC GAGTTA TTC TGC 
CTG CTC AGC CAC-3′, respectively. The PCR products were digested 
with EcoRI and XhoI, and the resulting fragments were cloned into 
EcoRI- and XhoI-digested pGEX6P3 (GE Healthcare). For genera-
tion of a bacterial expression plasmid encoding human Myo1E amino 
acids 1,039 to 1,108 (SH3), the corresponding cDNA was amplified 
from Myo1E(ΔMotor) cDNA by PCR with the forward primer 5′-
GCGAA TTCAGC AGG GGG CAG ACC CAAG-3′ (underline indicates 
the EcoRI site) and the reverse primer 5′-GCCCTC GAGTCA GAT 
CTT GGT CAC ATAG-3′ or 5′-GCCCTC GAGGAT CTT GGT CAC ATA 
GTTG-3′ (underline indicates XhoI sites). The PCR products were di-
gested with EcoRI and XhoI, and the resulting fragments were cloned 
into EcoRI- and XhoI-digested pGEX6P3 for GST-Myo1E(SH3) or 
into EcoRI- and XhoI-digested pET24b (Novagen) for His6-tagged 
Myo1E(SH3), respectively.
Mutagenesis of Asp209 and Asp210 of SH3P2 to Ala (C2A) was 
performed with the use of a PrimeSTAR Mutagenesis Basal kit (Takara 
Bio Inc.) and with pEGFP-C1-SH3P2 and the mutagenic primers (for-
ward and reverse, respectively) 5′-TAT CTC GCT GCT GAA GAC TCA 
GAT TAA CTC-3′ and 5′-GTC TTC AGC AGC GAG ATA GTC CTC GGC 
ATT-3′. For mutagenesis of Glu205, Asp206, Asp209, Asp210, Glu211, and 
Asp212 of SH3P2 to Ala (C6A), Glu205 and Asp206 were changed to Ala 
(205/206A) with pEGFP-C1-SH3P2 and the mutagenic primers 5′-AAT 
GCC GCG GCC TAT CTC GAT GAT GAA GAC-3′ and 5′-GAG ATA GGC 
CGC GGC ATT GCT TAA TGT TCG-3′; Asp209 and Asp210 were then 
changed to Ala (C4A) with pEGFP-C1-205/206A and the mutagenic 
primers 5′-TAT CTC GCT GCT GAA GAC TCA GAT TAA CTC-3′ and 
5′-GTC TTC AGC AGC GAG ATA GGC CGC GGC ATT-3′; and Glu211 
and Asp212 were then changed to Ala (C6A) with pEGFP-C1-C4A and 
the mutagenic primers 5′-GCT GCT GCA GCC TCA GAT TAA CTC GAC 
GGT-3′ and 5′-ATC TGA GGC TGC AGC AGC GAG ATA GGC CGC-3′. 
Mutagensesis of Lys1048 and Lys1050 of Myo1E(ΔSH3) to Ala (2AΔSH3) 
was performed with pEGFP-C1-Myo1E(ΔSH3) and the mutagenic 
primers 5′-CAG CCC GCG CCC GCG TGA CTC GAC GGT ACC GCG-3′ 
and 5′-GAG TCA CGC GGG CGC GGG CTG GGG CTT GGG TCT-3′.
The GST- or His6-tagged protein fragments were expressed in 
Escherichia coli and purified as described previously (Tanimura et al., 
1998, 2007). For recombinant SH3P2 or SH3P2(ΔPR), the GST tag 
was cleaved with PreScission protease (GE Healthcare). Transfection 
of tumor cells with pEGFP-C1–based plasmids was performed with the 
use of Lipofectamine 2000 (Invitrogen).
Production of and infection with recombinant lentiviruses
An human immunodeficiency virus–1–based lentiviral vector system 
was obtained from D. Trono (École Polytechnique Fédérale de Lau-
sanne, Switzerland; Zufferey et al., 1997). A cDNA for FLAG-tagged 
human Myo1E (Myo1E-FLAG) was introduced into pRRL. Recombi-
nant lentiviruses were produced by transfection of HEK293T cells in 
a 10-cm dish for 72 h with 1.5 µg pMD2.G, 3.0 µg pMDLg/pRRE, 1.5 
µg pRSV-Rev, and 6.0 µg pRRL-CMV-GFP-Sin-18 or pRRL-CMV-
Myo1E-FLAG. Culture supernatants containing lentiviruses were cen-
trifuged at 1,200 g for 10 min, and the resulting soluble fraction was 
passed through a 0.45-µm filter (EMD Millipore). Lentiviruses in the 
filtrate were then collected by precipitation with polyethylene glycol 
and suspended in 500 µl Opti-MEM (Gibco). MKN1 cells that had been 
transfected with Myo1E siRNA for 24 h in a 24-well plate were in-
fected with recombinant lentiviruses encoding GFP or Myo1E-FLAG 
(10 µl of the respective virus suspension) for 24 h and then incubated in 
fresh culture medium for 24 h.
RNAi
siRNAs for human Myo1E (#1, Stealth select RNAi MYO1E-
HSS106891; #2, Stealth select RNAi MYO1EHSS106893) and for 
human SH3P2 (#449 and #500; Tanimura et al., 2011) were obtained 
from Invitrogen. The sequences 5′-GAG TAC GGA TTA AGC GGC CGA 
AGAA-3′ (Myo1E #3) and 5′-GAG GCG ACG GTT GTA AGC CAG 
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ACAA-3′ (SH3P2 #36) were designed to generate siRNA duplexes 
specific for the 5′-UTR sequence of human Myo1E or SH3P2 mRNAs 
(Invitrogen). Stealth RNAi Negative Control Medium GC Duplex was 
used as a control (Invitrogen). Subconfluent cultures of cells were 
transfected with siRNAs (20 nM) for 48 or 72 h with the use of Lipo-
fectamine RNAiMAX (Invitrogen).
In-gel digestion and protein identification
Bands of interest were excised from Coomassie brilliant blue–stained 
gels, cut into 1-mm pieces, dehydrated with 50% acetonitrile containing 
25 mM NH4HCO3, and dried with the use of a vacuum centrifuge. The gel 
pieces were rehydrated with digestion solution (50 mM NH4HCO3 con-
taining sequencing-grade modified trypsin [Promega] at 10 µg/ml) and 
incubated overnight at 37°C, and the resulting peptides were extracted 
with 5% trifluoroacetic acid in 50% acetonitrile. The peptide mixture was 
subjected to liquid chromatography, electrospray ionization, and tandem 
MS analysis (LTQ-XL; Thermo Fisher Scientific). MS/MS data were 
extracted with Proteome Discoverer v.3.3 (Thermo Fisher Scientific), 
and spectra were searched against a human subdatabase obtained from 
the public nonredundant protein database (International Protein Index 
version 3.84 presented by The European Bioinformatics Institute). Each 
protein was identified on the basis of more than two unique peptides.
Immunofluorescence microscopy
Cells grown on glass coverslips and exposed to various agents were 
fixed with 3.7% paraformaldehyde and permeabilized with 0.25% 
Triton X-100. After blocking of nonspecific sites with 2.5% BSA in 
PBS, the cells were immunostained with antibodies to Myo1E (1/200 
dilution) or to SH3P2 (1/200), and immune complexes were detected 
with Alexa Fluor 488– or 546–conjugated goat antibodies to rabbit 
IgG (1/200 dilution; Molecular Probes). F-actin was visualized with 
the use of Alexa Fluor 350–labeled phalloidin (Molecular Probes). 
Images were acquired with an Axiovert 200M microscope equipped 
with a FluoArc mercury lamp, a Plan-NEO FLU AR 40×/0.75 objec-
tive lens, and an AxioCam MRm camera (ZEI SS). For comparison of 
the localization of Myo1E or of EGFP-Myo1E and its mutants, images 
were acquired with the same exposure time in respective experiments 
(typically 2 s for Myo1E and 5 s for EGFP). Images were analyzed with 
AxioVision software version 4.8.2 (ZEI SS).
Statistical analysis
Data are presented as means ± SD and were analyzed with the two-tailed 
Student’s t test. A p-value of <0.05 was considered statistically significant.
Online supplemental material
Fig. S1 shows the sequence alignment for the N-terminal PR region and 
C-terminal acidic amino acid cluster of mammalian SH3P2 proteins as 
well as for the TH2 domain of mammalian Myo1E proteins. Fig. S2 
shows the putative binding interfaces for the interaction between SH3P2 
and Myo1E. Fig. S3 shows that LY294002 suppresses the serum-induced 
production of PI(3,4,5)P3 and localization of Myo1E to lamellipodial 
tips. Fig. S4 shows the membrane association of recombinant Myo1E 
is suppressed by prior incubation with GST-SH3P2. Fig. S5 shows 
quantitative immunoblot analysis of Myo1E in the cytosolic and 
membrane fractions of MKN1 cells. Online supplemental material is 
available at http ://www .jcb .org /cgi /content /full /jcb .201503123 /DC1.
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